Israel Englander’s Calumet Specialty Products CLMT Stock Holding History

Israel Englander’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Buy	305,557 +266,784	+688%	+$8.97M	﹤0.01%	2192
2026 Q1	$1.39M	Buy	38,773 +24,871	+179%	+$644K	﹤0.01%	4148
2025 Q4	$276K	Sell	13,902 -21,256	-60%	-$409K	﹤0.01%	5314
2025 Q3	$642K	Sell	35,158 -172,807	-83%	-$2.84M	﹤0.01%	4921
2025 Q2	$3.28M	Sell	207,965 -1,471,010	-88%	-$18.7M	﹤0.01%	3413
2025 Q1	$21.3M	Buy	+1,678,975	New	+$26.4M	0.01%	1446
2024 Q4	–	Sell	-164,009	Closed	-$2.92M	–	6014
2024 Q3	$2.92M	Buy	+164,009	New	+$2.63M	﹤0.01%	3347

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Israel Englander's CLMT Position: Q2 2026 in Review

Israel Englander increased its Calumet Specialty Products (CLMT) stake by 688% in Q2 2026, buying an estimated $8.97M and bringing the position to 305,557 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Israel Englander first reported a position in CLMT in Q3 2024 and has held it in 7 quarters since. The position peaked at $21.3M in Q1 2025. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Israel Englander held 305,557 shares of Calumet Specialty Products worth $11M as of Q2 2026.
Israel Englander bought 266,784 Calumet Specialty Products shares in Q2 2026, an estimated $8.97M.
Calumet Specialty Products made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2192 holding.
Israel Englander first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 7 quarters since.
Israel Englander's Calumet Specialty Products position peaked at $21.3M in Q1 2025.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.